AI is increasingly being combined with prescription drugs and other therapies in the push to personalize medicine.
But that's making it harder to define whether a compound or an algorithm is actually doing the healing.
The big picture: Optimism over new ways to deliver customized, real-time care in patients' homes is being tempered by legal and regulatory questions about how to treat hybrid products that learn and evolve from their interactions with patients.
